Enhancing the precision of clinical assessment in juvenile idiopathic arthritis through the JADAS

Area of Science:

• Pediatric Rheumatology
• Clinical Assessment Tools
• Disease Activity Measurement

Background:

• Composite scores pragmatically measure disease activity in juvenile idiopathic arthritis (JIA).
• The Juvenile Arthritis Disease Activity Score (JADAS) was the first composite score for JIA, integrating physician and patient assessments, active joint counts, and acute phase reactants.
• Subsequent JADAS versions, including clinical (cJADAS) and systemic (sJADAS) JIA specific scores, have been developed.

Purpose of the Study:

• To review the evolution and developmental aspects of various Juvenile Arthritis Disease Activity Score (JADAS) versions.
• To highlight the significance of JADAS cutoff values for defining disease activity states and guiding treatment targets.
• To introduce a novel JADAS version utilizing parent/patient-reported outcomes for enhanced remote monitoring.

Main Methods:

• Review of the literature on the development and validation of JADAS and its variants.
• Analysis of the components and scoring of different JADAS versions.
• Discussion of the application of JADAS cutoffs in clinical practice and treat-to-target strategies.

Main Results:

• Established JADAS versions include the original, cJADAS (without acute phase reactant), and sJADAS (for systemic JIA).
• Defined cutoff values for JADAS enable classification of disease activity states (inactive, minimal, moderate, high) in JIA.
• A recent JADAS version composed entirely of patient-reported outcomes facilitates remote patient monitoring.

Conclusions:

• JADAS and its variants provide essential tools for assessing and managing JIA disease activity.
• JADAS cutoffs are valuable for setting therapeutic goals within a treat-to-target approach.
• Patient-reported outcome-based JADAS versions enhance telemedicine capabilities for JIA care and healthcare system efficiency.